RNA-seq gene expression profile of SUM159PT breast cancer cell line upon manipulation of two TDMD triggers, NREP and SERPINE1
RNA-seq (gene expression) · human · 16 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 16 samples: 5 × SUM159PT_SERPINE1_MRE_KO_clone vs 4 × SUM159PT_CRISPRi_NREP_KD_sgRNA vs 3 × SUM159PT_wild_type_unedited_clone vs 3 × SUM159PT_CRISPRi_CTRL_sgRNAGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE236783_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA992422 and SRA study SRP447928. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 4 replicated groups read from 16 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7576222 SUM159PT_wild_type_no_Cas9_clone_1
- GSM7576223 SUM159PT_wild_type_unedited_clone_2 SUM159PT_wild_type_uned…
- GSM7576225 SUM159PT_wild_type_unedited_clone_3 SUM159PT_wild_type_uned…
- GSM7576227 SUM159PT_wild_type_unedited_clone_4 SUM159PT_wild_type_uned…
- GSM7576229 SUM159PT_SERPINE1_MRE_KO_clone_1 SUM159PT_SERPINE1_MRE_K…
- GSM7576231 SUM159PT_SERPINE1_MRE_KO_clone_2 SUM159PT_SERPINE1_MRE_K…
- GSM7576232 SUM159PT_SERPINE1_MRE_KO_clone_3 SUM159PT_SERPINE1_MRE_K…
- GSM7576234 SUM159PT_SERPINE1_MRE_KO_clone_4 SUM159PT_SERPINE1_MRE_K…
- GSM7576236 SUM159PT_SERPINE1_MRE_KO_clone_5 SUM159PT_SERPINE1_MRE_K…
- GSM7576237 SUM159PT_CRISPRi_CTRL_sgRNA_1 SUM159PT_CRISPRi_CTRL_s…
- GSM7576239 SUM159PT_CRISPRi_CTRL_sgRNA_2 SUM159PT_CRISPRi_CTRL_s…
- GSM7576240 SUM159PT_CRISPRi_CTRL_sgRNA_3 SUM159PT_CRISPRi_CTRL_s…
- GSM7576242 SUM159PT_CRISPRi_NREP_KD_sgRNA_1 SUM159PT_CRISPRi_NREP_K…
- GSM7576244 SUM159PT_CRISPRi_NREP_KD_sgRNA_2 SUM159PT_CRISPRi_NREP_K…
- GSM7576245 SUM159PT_CRISPRi_NREP_KD_sgRNA_3 SUM159PT_CRISPRi_NREP_K…
- GSM7576247 SUM159PT_CRISPRi_NREP_KD_sgRNA_4 SUM159PT_CRISPRi_NREP_K…
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE279486 Permeable lung vasculature creates chemoresistant endothelial niche by producing SERPINE1 at breast cancer metastatic sites 6 samples shares serpine1, breast
- GSE259214 The Transcriptomic Analysis of Profibrinolytic (PLAUR) and Fibrinolytic Inhibitor (SERPINE1, A2M) Genes in COVID-19 Patients and Its Relationship with D-Dimer Levels 50 samples shares serpine1
- GSE22917 SAGE-Seq gene expression profiles of Hs578T, MCF7, and SUM159PT cells treated with STAT3 or non-targeting siRNAs, DMSO, or CXCR2, PTGIS, HAS1, PFKFB3, JAK, or NQO1 inhibitor 27 samples shares sum159pt
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.